GIP and bariatric surgery

Raghavendra S. Rao, Subhash Kini

Research output: Contribution to journalReview articlepeer-review

87 Scopus citations

Abstract

Bariatric surgery is the most effective modality of achieving weight loss as well as the most effective treatment for type 2 diabetes mellitus (T2DM). Glucose-dependent insulinotropic polypeptide (GIP) is an incretin and is implicated in the pathogenesis of obesity and T2DM. Its role in weight loss and resolution of T2DM after bariatric surgery is very controversial. We have made an attempt to review the physiology of GIP and its role in weight loss and resolution of T2DM after bariatric surgery. We searched PubMed and included all relevant original articles (both human and animal) in the review. Whereas most human studies have shown a decrease in GIP post-malabsorptive bariatric surgery, the role of GIP in bariatric surgery done in animal experiments remains inconclusive.

Original languageEnglish
Pages (from-to)244-252
Number of pages9
JournalObesity Surgery
Volume21
Issue number2
DOIs
StatePublished - Feb 2011

Keywords

  • BPD
  • Bariatric surgery
  • GIP
  • GLP-1
  • Ileal transposition
  • LAGB
  • RYGB
  • Sleeve gastrectomy
  • TCF7L2

Fingerprint

Dive into the research topics of 'GIP and bariatric surgery'. Together they form a unique fingerprint.

Cite this